Intravenous ketamine and progressive cholangiopathy in COVID-19 patients

Lignende værker

• Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
  af: Deltenre, Pierre, et al.
  Udgivet: (2021)
• Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
  af: Mallet, Vincent
  Udgivet: (2021)
• Ketamine-induced cholangiopathy in ARDS patients
  af: de Tymowski, Christian, et al.
  Udgivet: (2021)
• Ketamine in COVID‐19 patients: Thinking out of the box
  af: Akinosoglou, Karolina, et al.
  Udgivet: (2020)
• Ketamine use in the COVID-19 era: be cautious!
  af: Suri, Aditi, et al.
  Udgivet: (2020)